
EASI-Genomics
@easigenomics
We provide easy and seamless DNA sequencing technologies to researchers from academia and industry #FAIRdata #CitSciELSI #TransnationalAccess @EU_H2020
ID: 1098621108759265280
https://www.easi-genomics.eu 21-02-2019 16:30:58
238 Tweet
596 Followers
260 Following

Dr. Marzese from the Cancer Epigenetics Laboratory of the Health Research Institute of the Balearic Islands provided a sneak peak to 2 manuscripts that resulted from collaboration with EASI-Genomics 👏👏 IdISBa Cancer Epigenetics Lab @DMarzese IdISBa


🔬Did you know that EASI-Genomics...❓ ➡️... has provided access to cutting-edge #DNA #sequencing tech to #researchers from academia and industry ➡️... has made 5 calls ➡️... has carried out 127 user projects from 26 different countries ➡️... has offered 171 services


For the closing talk of the EASI-Genomics summit, Ann-Christine Syvänen guided us down memory lane of the major developments in the rapidly advancing field of #Genomics 🧬 SciLifeLab NGI Sweden Max Delbrück Center Charité - Universitätsmedizin Berlin CNAG


Last week, we held our Final EASI-Genomics Summit. This would not have been possible without the support from the #H2020 funding programme. 🎉Let's celebrate #EuropeDay2023 🎉 Centre for Genomic Regulation (CRG) CNAG Max Delbrück Center Charité - Universitätsmedizin Berlin



🤓👌Very interesting critical review & perspectives about the paradigms of FFPE-DNA #sequencing from EASI-Genomics & collaborators. Recently published in Nucleic Acids Res 👇👇👇

📢New paper out in 'G3: Genes, Genomes, Genetics' Oxford Academic! 🐙The chromosome-level genome for the common octopus becomes a reference model to discover more about how the brain works 🌍An international #research in the framework of EASI-Genomics ➡️cnag.eu/news/chromosom…


💫The study was funded by the international project EASI-Genomics ➕A collaborative initiative coordinated by Ivo Gut (the director of #CNAG) whose aim is to provide #DNA sequencing technologies to researchers from academia & industry ℹ️academic.oup.com/g3journal/adva… #Researchpaper











✨New advances in breast cancer! A study led by Vall d’Hebron Institute of Oncology (VHIO), in collaboration with #CNAG, discovered that combining a common drug (PARP inhibitors) with a new immune booster (STING) helps fight tumors that have become resistant 📎aacrjournals.org/cancerres/arti… #BreastCancer #CancerResearch

